NEW YORK-- ( BUSINESS WIRE )--1stdibs.com, Inc. (NASDAQ: DIBS), a leading online marketplace for luxury design products ("1stDibs" or the "Company"), today reported financial results for its fourth ...

Q4 2024 Earnings Call Transcript February 27, 2025 Ironwood Pharmaceuticals, Inc. misses on earnings expectations. Reported ...

Results of the Planned Interim Analysis and Update on Topline Read-out for the Essential3 Program: The Independent Data ...

AnalytixInsight Inc. (TSXV: ALY) (OTCQB: ATIXF) ("AnalytixInsight", or the "Company") today announced that it has filed a restatement of its previously issued financial statements for the period ...

Operator: Please standby. Welcome, ladies and gentlemen, to the Fourth Quarter and Fiscal Year 2024 Earnings Conference Call ...

FY Revenue of $291.3 million, up 9% over 2023; Delivered FY 2024 net income of $12.5 million or 4% margin; FY adjusted EBITDA increased 23% over 2023 and was $92.3 million or 32% margin; Revenue ...

Organogenesis ( ORGO -5.54%) Q4 2024 Earnings Call Feb 27, 2025, 5:00 p.m. ET ...

Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ETCompany ParticipantsPatrick Jobin - Senior Vice President of ...

Intermap's CEO Patrick A. Blott, CFO Jennifer Bakken and COO Jack Schneider will host a live webinar on Thursday, March 27, 2025, at 5:00 pm ET to review the results, provide Company updates and ...

Cytek will host a conference call to discuss its fourth quarter and year end 2024 financial results on Thursday, February 27, 2024, at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. A webcast of the ...

SOUTH SAN FRANCISCO, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today reported financial results for the fourth quarter and year ended December 31, 2024, and ...

Analysts have set 12-month price targets for ACADIA Pharmaceuticals, revealing an average target of $25.0, a high estimate of $28.00, and a low estimate of $20.00. A 2.91% drop is evident in the ...